Marrone Bio Innovations

Marrone Bio Innovations (MBI) is dedicated to advancing the pest management industry with effective and environmentally responsible bio-based pest management and plant health products. MBI’s products promote plant health and control weeds, plant diseases and pests in agriculture, turf and ornamental, and water applications. Used around the globe, MBI’s high-performance, competitively-priced solutions help customers improve productivity and profitability, operate more sustainably, and reduce risk in their operations
Company Growth (employees)
Type
Public
HQ
Davis, US
Founded
2006
Size (employees)
86 (est)
Marrone Bio Innovations was founded in 2006 and is headquartered in Davis, US

Key People at Marrone Bio Innovations

Pam Marrone

Pam Marrone

CEO and Founder, Board of Directors
Donald J. Glidewell

Donald J. Glidewell

CFO
Keith Pitts

Keith Pitts

Vice President, Regulatory Affairs

Marrone Bio Innovations Office Locations

Marrone Bio Innovations has an office in Davis
Davis, US (HQ)
2121 Second St.
Davis, US
1540 Drew Ave

Marrone Bio Innovations Data and Metrics

Marrone Bio Innovations Financial Metrics

Marrone Bio Innovations's revenue was reported to be $9.8 m in FY, 2015
$, USD

Revenue (FY, 2015)

9.8 m

Revenue growth (FY, 2014 - FY, 2015), %

793%

Gross profit (FY, 2015)

545 k

Gross profit margin (FY, 2015), %

6%

Net income (FY, 2015)

(43.7 m)

EBIT (FY, 2015)

(39.5 m)

Market capitalization (22-Jun-2017)

34.8 m

Closing share price (22-Jun-2017)

1.1

Cash (31-Dec-2015)

19.8 m
Marrone Bio Innovations's current market capitalization is $34.8 m.
$, USDFY, 2013Y, 2014FY, 2015

Revenue

14.5 m1.1 m9.8 m

Revenue growth, %

(92%)793%

Gross profit

3.8 m545 k

Gross profit Margin, %

26%6%

Operating expense total

32.8 m15.2 m40 m

EBIT

(29 m)(15.5 m)(39.5 m)

EBIT margin, %

(200%)(1416%)(403%)

Interest expense

6 m669 k2.8 b

Interest income

49 k17 k51 m

Pre tax profit

(28.5 m)(16.2 m)(43.7 b)

Net Income

(28.5 m)(16.2 m)(43.7 m)
$, USDFY, 2013FY, 2014FY, 2015

Cash

24.5 m35.3 m19.8 m

Accounts Receivable

6.2 m1.8 m2.3 m

Inventories

1.7 m1.3 m1.3 m

Current Assets

58.7 m54.7 m36 m

PP&E

9.4 m20.2 m18.4 m

Total Assets

68.9 m77.2 m71.8 m

Accounts Payable

4.5 m5.8 m2 m

Current Liabilities

11.7 m31.2 m12.9 m

Additional Paid-in Capital

147.2 m193.1 m201.6 m

Retained Earnings

(105.4 m)(159.8 m)(203.6 m)

Total Equity

41.8 m33.2 m(2 m)

Financial Leverage

1.6 x2.3 x-35.5 x
$, USDFY, 2013FY, 2014FY, 2015

Net Income

(28.5 m)(16.2 m)(43.7 b)

Depreciation and Amortization

976 k

Accounts Receivable

(3.4 m)1.8 m

Inventories

(6.8 m)1.3 m

Accounts Payable

1.7 m5.8 m

Cash From Operating Activities

(34 m)(15.5 m)

Purchases of PP&E

(4 m)

Cash From Investing Activities

(17.7 m)

Long-term Borrowings

(9.4 m)

Cash From Financing Activities

66.1 m
$, USDY, 2015

Revenue/Employee

91.3 k

Financial Leverage

-35.5 x

Marrone Bio Innovations Market Value History

Marrone Bio Innovations Job Categories

Marrone Bio Innovations Online and Social Media Presence

Marrone Bio Innovations News and Updates

Marrone Bio Innovations Company Life and Culture

You may also be interested in